# Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

> **NCT04300101** · — · RECRUITING · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 300 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **OTHER:** Prospective cohort
- **OTHER:** Retrospective cohort

## Key facts

- **NCT ID:** NCT04300101
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-14
- **Primary completion:** 2026-05
- **Final completion:** 2028-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04300101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04300101, "Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04300101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*